Squamous cell carcinoma of the anal canal: Utilization and outcomes of recommended treatment in the United States

Annals of Surgical Oncology

Volumn 15, Issue 7, 2008, Pages 1948-1958

  Bilimoria, Karl Y ^a,b   Bentrem, David J ^a   Ko, Clifford Y ^b,c   Stewart, Andrew K ^b   Winchester, David P ^a,b,d   Talamonti, Mark S ^a,d   Halverson, Amy L ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b American College of Surge   (United States)

^c VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^d Evanston Northwestern Healthcare ^*  (United States)

Author keywords

Anal neoplasm; Chemotherapy; National Cancer Data Base; Radiation; Squamous cell carcinoma of the anal canal; Surgery; Survival; Treatment

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ANUS CARCINOMA; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEALTH CARE UTILIZATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; UNITED STATES;

AGED; AGED, 80 AND OVER; ANUS NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; GUIDELINE ADHERENCE; HUMANS; MALE; NEOPLASM STAGING; NEOPLASMS, SQUAMOUS CELL; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES;

EID: 46149115144     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-008-9905-2     Document Type: Article

References (48)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin 2007; 57:43-66
2. Johnson LG, Madeleine MM, Newcomer LM, et al. Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973-2000. Cancer 2004; 101:281-8
3. Goldie SJ, Kuntz KM, Weinstein MC, et al. The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men. JAMA 1999; 281:1822-9
4. Ryan DP, Compton CC, Mayer RJ. Carcinoma of the anal canal. N Engl J Med 2000; 342:792-800
5. Nigro ND, Vaitkevicius VK, Considine B Jr. Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum 1974; 17:354-6
6. Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research. Lancet 1996; 348:1049-54
7. Bartelink H, Roelofsen F, Eschwege F, et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 1997; 15:2040-9
8. Flam M, John M, Pajak TF, et al. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol 1996; 14:2527-39
9. Engstrom PF, Benson AB 3rd, Chen YJ, et al. Anal canal cancer clinical practice guidelines in oncology. J Natl Compr Canc Netw 2005; 3:510-5
10. McGlynn EA, Asch SM, Adams J, et al. The quality of health care delivered to adults in the United States. N Engl J Med 2003; 348:2635-45
11. American Cancer Society, Cancer Facts and Figures. http://www.cancer.org/ docroot/STT/content/STT_1x_Cancer_Facts__Figures_2007.asp [accessed January 21, 2007]
12. Winchester DP, Stewart AK, Bura C, et al. The National Cancer Data Base: a clinical surveillance and quality improvement tool. J Surg Oncol 2004; 85:1-3
13. Bilimoria KY, Stewart AK, Winchester DP, et al. The National Cancer Data Base: a powerful initiative to improve cancer care in the United States. Ann Surg Oncol 2008; 15:683-90
14. International Classification of Disease for Oncology, 3rd ed. Geneva: World Health Organization, 2000
15. Facility Oncology Registry Data Standards. Chicago: Commission on Cancer, 2004
16. Department of Health and Human Services. The International Classification of Diseases, 9th revised. clinical modification: ICD-9-CM. Washington, DC: Government Printing Office, 1998
17. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40:373-83
18. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992; 45:613-9
19. United States Census Bureau. Census 2000. http://www.census.gov/main/www/ cen2000.html [accessed January 21, 2007]
20. Hosmer J, Lemeshow S. Applied logistic regression. New York: John Wiley & Sons, 1999
21. Kaplan E, Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53:457-81
22. Cox D. Regression models and life tables. J R Stat Soc 1972; 34:187-220
23. Myerson RJ, Karnell LH, Menck HR. The National Cancer Data Base report on carcinoma of the anus. Cancer 1997; 80:805-15
24. Beahrs OH, Wilson SM. Carcinoma of the anus. Ann Surg 1976; 184:422-8
25. Cummings BJ, Thomas GM, Keane TJ, et al. Primary radiation therapy in the treatment of anal canal carcinoma. Dis Colon Rectum 1982; 25:778-82
26. Touboul E, Schlienger M, Buffat L, et al. Epidermoid carcinoma of the anal canal. Results of curative-intent radiation therapy in a series of 270 patients. Cancer 1994; 73:1569-79
27. Cummings BJ, Keane TJ, O'Sullivan B, et al. Epidermoid anal cancer: treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C. Int J Radiat Oncol Biol Phys 1991; 21:1115-25
28. Chiao EY, Krown SE, Stier EA, et al. A population-based analysis of temporal trends in the incidence of squamous anal canal cancer in relation to the HIV epidemic. J Acquir Immune Defic Syndr 2005; 40:451-5
29. Maggard MA, Beanes SR, Ko CY. Anal canal cancer: a population-based reappraisal. Dis Colon Rectum 2003; 46:1517-23; discussion 1523-4; author reply 1524
30. Bilimoria KY, Stewart AK, Palis BE, et al. Adequacy and importance of nodal examination for colon cancer in the elderly. J Am Coll Surg 2008; 206:247-54
31. Bilimoria KY, Talamonti MS, Ko CY, et al. Effect of hospital volume on lymph node evaluation for gastrointestinal malignancies. Arch Surg 2007; In press
32. Bilimoria KY, Balch C, Bentrem DJ, et al. Complete lymph node dissection for sentinel node-positive melanoma: assessment of practice patterns in the United States. Ann Surg Onc 2008; In press
33. Bilimoria KY, Bentrem DJ, Ko CY, et al. Multimodality therapy for pancreatic cancer in the U.S.: utilization, outcomes, and the effect of hospital volume. Cancer 2007; 110:1227-34
34. Bilimoria KY, Bentrem DJ, Linn JG, et al. Utilization of total thyroidectomy for papillary thyroid cancer in the United States. Surgery 2007; 142:906-13
35. Reid-Lombardo KM, Gay G, Patel-Parekh L, et al. Treatment of gastric adenocarcinoma may differ among hospital types in the United States, a report from the National Cancer Data Base. J Gastrointest Surg 2007; 11:410-9; discussion 419-20
36. Morris AM, Billingsley KG, Baxter NN, et al. Racial disparities in rectal cancer treatment: a population-based analysis. Arch Surg 2004; 139:151-5; discussion 156
37. Hershman D, McBride R, Jacobson JS, et al. Racial disparities in treatment and survival among women with early-stage breast cancer. J Clin Oncol 2005; 23:6639-46
38. Eloubeidi MA, Desmond RA, Wilcox CM, et al. Prognostic factors for survival in pancreatic cancer: a population-based study. Am J Surg 2006; 192:322-9
39. Unequal Treatment: Confronting Racial, Ethnic Disparities in Health Care. Vol. xvi. Washington DC: National Academies Press, 2003
40. Liu JH, Zingmond DS, McGory ML, et al. Disparities in the utilization of high-volume hospitals for complex surgery. JAMA 2006; 296:1973-80
41. Margolis ML, Christie JD, Silvestri GA, et al. Racial differences pertaining to a belief about lung cancer surgery: results of a multicenter survey. Ann Intern Med 2003; 139:558-63
42. National Healthcare Quality Report, 2006. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/qual/nhqr06/nhqr06.htm [accessed December 5, 2007]
43. Wexler A, Berson AM, Goldstone SE, et al. Invasive anal squamous-cell carcinoma in the HIV-positive patient: outcome in the era of highly active antiretroviral therapy. Dis Colon Rectum 2008; 51:73-81
44. Edelman S, Johnstone PA. Combined modality therapy for HIV-infected patients with squamous cell carcinoma of the anus: outcomes and toxicities. Int J Radiat Oncol Biol Phys 2006; 66:206-11
45. Blazy A, Hennequin C, Gornet JM, et al. Anal carcinomas in HIV-positive patients: high-dose chemoradiotherapy is feasible in the era of highly active antiretroviral therapy. Dis Colon Rectum 2005; 48:1176-81
46. Graf R, Wust P, Hildebrandt B, et al. Impact of overall treatment time on local control of anal cancer treated with radiochemotherapy. Oncology 2003; 65:14-22
47. Nilsson PJ, Svensson C, Goldman S, et al. Epidermoid anal cancer: a review of a population-based series of 308 consecutive patients treated according to prospective protocols. Int J Radiat Oncol Biol Phys 2005; 61:92-102
48. Mangione-Smith R, DeCristofaro AH, Setodji CM, et al. The quality of ambulatory care delivered to children in the United States. N Engl J Med 2007; 357:1515-23